Skip to Main content Skip to Navigation
Journal articles

Chemical Metabolic Inhibitors For The Treatment Of Blood-Borne Cancers.

Abstract : : Tumor cells, including leukemic cells, remodel their bioenergetic system in favor of aerobic glycolysis. This process is called "the Warburg effect" and offers an attractive pharmacological target to preferentially eliminate malignant cells. In addition, recent results show that metabolic changes can be linked to tumor immune evasion. Mouse models demonstrate the importance of this metabolic remodeling in leukemogenesis. Some leukemias, although treatable, remain incurable and resistance to chemotherapy produces an elevated percentage of relapse in most leukemia cases. Several groups have targeted the specific metabolism of leukemia cells in preclinical and clinical studies to improve the prognosis of these patients, i.e. using L-asparaginase to treat pediatric acute lymphocytic leukemia (ALL). Additional metabolic drugs that are currently being used to treat other diseases or tumors could also be exploited for leukemia, based on preclinical studies. Finally, we discuss the potential use of several metabolic drugs in combination therapies, including immunomodulatory drugs (IMiDs) or immune cell-based therapies, to increase their efficacy and reduce side effects in the treatment of hematological cancers.
Document type :
Journal articles
Complete list of metadatas

Cited literature [109 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01867009
Contributor : Monique Frei <>
Submitted on : Tuesday, December 10, 2013 - 12:10:20 PM
Last modification on : Thursday, June 11, 2020 - 11:16:17 AM
Long-term archiving on: : Saturday, April 8, 2017 - 5:36:59 AM

File

chemical_metabolic_inhibitorBe...
Files produced by the author(s)

Identifiers

Collections

Citation

Martin Villalba, Nuria Lopez-Royuela, Ewelina Krzywinska, Moeez Rathore, Robert Hipskind, et al.. Chemical Metabolic Inhibitors For The Treatment Of Blood-Borne Cancers.. Current Medicinal Chemistry Anticancer Agents, Bentham Science Publishers, 2014, 14 (2), pp.223-32. ⟨10.2174/18715206113136660374⟩. ⟨inserm-01867009v2⟩

Share

Metrics

Record views

1116

Files downloads

344